F
Feng Shen
Researcher at Second Military Medical University
Publications - 403
Citations - 12498
Feng Shen is an academic researcher from Second Military Medical University. The author has contributed to research in topics: Hepatocellular carcinoma & Medicine. The author has an hindex of 46, co-authored 313 publications receiving 8315 citations.
Papers
More filters
Journal ArticleDOI
ASO Visual Abstract: TBS-Based Preoperative Score to␣Predict Non-transplantable␣Recurrence and␣Identify Candidates for␣Upfront Resection Versus Transplantation for␣Hepatocellular Carcinoma
Henrique Araújo Lima,Zorays Moazzam,Yutaka Endo,Laura Alaimo,C. Shaikh,M. M. Munir,Vivian Resende,A. Guglielmi,Hugo Marques,François Cauchy,Vincent W. T. Lam,George A. Poultsides,Irinel Popescu,Sorin Alexandrescu,Guillaume Morel,Thomas J. Hugh,Itaru Endo,Minoru Kitago,Feng Shen,Timothy M. Pawlik +19 more
Journal ArticleDOI
Effect of different PD-1 inhibitor combination therapies for unresectable intrahepatic cholangiocarcinoma.
Zhengqing Lei,Weihu Ma,Anfeng Si,Yuhua Zhang,Facai Yang,Q. Yu,Haolan Tang,Jiahua Zhou,Kui Wang,Yufu Tang,Tao Han,Guo-Wen Yin,Jinhong Chen,Xiu-Feng Liu,Hua Zhao,Decai Yu,Tao Luo,Qing Wang,Mao-Hui Yan,Xianhai Mao,Jing Li,Kai Wang,Jingdong Li,Yongyi Zeng,De-quan Ding,Tingsong Chen,Xiaofeng Wu,Yongxiang Xia,Kanglong Wang,Wei-Xing Guo,Guangyu Zhu,Shanshan Gao,Norbert Hüser,Wan Yee Lau,Tianqiang Song,Shuqun Cheng,Feng Shen,Zhangjun Cheng +37 more
TL;DR: In this paper , the effect of anti-PD-1 combination therapies as the first-line treatments for intrahepatic cholangiocarcinoma (uICC) was compared.
Journal ArticleDOI
ASO Visual Abstract: Tumor Necrosis Impacts the Prognosis of Patients Undergoing Resection for T1 Intrahepatic Cholangiocarcinoma
Diamantis I. Tsilimigras,Aslam Ejaz,Jordan M. Cloyd,A. Guglielmi,Luca Aldrighetti,Matthew J. Weiss,Thomas W. Bauer,Sorin Alexandrescu,George A. Poultsides,Shishir K. Maithel,Hugo Marques,Guillaume Morel,Carlo Pulitano,Feng Shen,Olivier Soubrane,Bas Groot Koerkamp,Itaru Endo,Timothy M. Pawlik +17 more
TL;DR: This research presents a novel and scalable approach to regenerative medicine that combines traditional and innovative approaches to Hepatobiliopancreatic Surgery and Liver Transplantation.
Journal ArticleDOI
ASO Visual Abstract: Development and Validation of a Machine Learning Model to Predict Early Recurrence of Intrahepatic Cholangiocarcinoma.
Laura Alaimo,Henrique Araújo Lima,Zorays Moazzam,Yutaka Endo,Jason Yang,Andrea Ruzzenente,A. Guglielmi,Luca Aldrighetti,M.W. Weiss,Todd W. Bauer,Sorin Alexandrescu,George A. Poultsides,Shishir K. Maithel,Hugo Marques,Guillaume Morel,Carlo Pulitano,Feng Shen,François Cauchy,Bas Groot Koerkamp,Itaru Endo,Minoru Kitago,Timothy M. Pawlik +21 more
Journal ArticleDOI
Association of pringle maneuver with postoperative recurrence and survival following hepatectomy for hepatocellular carcinoma: A multicenter propensity score and competing-risks regression analysis
Shi-Chuan Tang,Yong-Kang Diao,Kong-ying Lin,Chao Li,Xiao Xu,Lei Liang,Qingjing Chen,Xian-ming Wang,Wei Gu,Ya-Hao Zhou,Ying Jian Liang,Ming Wang,Lanqing Yao,Timothy M. Pawlik,Feng Shen,Wan Yee Lau,Tian Yang,Y-Y. Zeng +17 more
TL;DR: Shi-Chuan Tang, Yong-Kang DIAO, Kong-Ying LIN, Chao LI, Xiao XU, Lei LIANG, Qing-Jing CHEN, Xian-Ming WANG, Fu-Bao LIU, Wei-Min GU, Ya-Hao ZHOU, Ying-Jian LIANG and Hong-Zhi LIU as discussed by the authors .